BCL2 apoptosis regulator (BCL2) antibody and antigen (Recombinant protein) GMP-h-BCL2
Diagnostic BCL2 apoptosis regulator (BCL2) antibodies (anti-BCL2 apoptosis regulator, anti-BCL2) and antigens (recombinant BCL2 apoptosis regulator (BCL2) protein) for Cancer, Inflammation/autoimmune/inflammatory disease, Neurodegenerative diseases BCL2 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Product information
Size: 1mg | 10mg | 100mg
| Catalog No. | Description | US $ Price (per mg) | First Order Discount | First Order Discount Price |
|---|---|---|---|---|
| GMP-h-BCL2-Ag01 | Recombinant human BCL2 Protein | 3090 | ||
| GMP-h-BCL2-Ab01 | Anti-human BCL2 mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
| GMP-h-BCL2-Ab02 | Anti-human BCL2 mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
| GMP-h-BCL2-Ab03 | Anti-human BCL2 human monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
| GMP-h-BCL2-Ab04 | Anti-human BCL2 human monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)
Product Description
| Cat No. of Products | GMP-h-BCL2-Ag01 |
| Product Name | Recombinant human BCL2 Protein |
| Target/Biomarker | BCL2 apoptosis regulator (BCL2) |
| Alias of Target/Biomarker | Bcl-2, PPP1R50 |
| Expression platform | mammalian |
| Bioactivity validation | BCL2 apoptosis regulator (BCL2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in BCL2 level test of Cancer, Inflammation/autoimmune/inflammatory disease, Neurodegenerative diseases () and related syndrome evaluation. |
| Tag | His |
| Products description | Recombinant human BCL2 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
| Formulation & Reconstitution | PBS liquid / Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-BCL2-Ab01, GMP-h-BCL2-Ab02 |
| Product Name | Anti-human BCL2 mouse monoclonal antibody (mAb) |
| Target/Biomarker | BCL2 apoptosis regulator (BCL2) |
| Alias of Target/Biomarker | Bcl-2, PPP1R50 |
| Expression platform | CHO |
| Bioactivity validation | Human BCL2 apoptosis regulator (BCL2) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other BCL2 apoptosis regulator (BCL2) antibodies in BCL2 level test of Cancer, Inflammation/autoimmune/inflammatory disease, Neurodegenerative diseases () and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human BCL2 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-BCL2-Ab03, GMP-h-BCL2-Ab04 |
| Product Name | Anti-human BCL2 human monoclonal antibody (mAb) |
| Target/Biomarker | BCL2 apoptosis regulator (BCL2) |
| Alias of Target/Biomarker | Bcl-2, PPP1R50 |
| Expression platform | CHO |
| Bioactivity validation | Human BCL2 apoptosis regulator (BCL2) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other BCL2 apoptosis regulator (BCL2) antibodies in BCL2 level test of Cancer, Inflammation/autoimmune/inflammatory disease, Neurodegenerative diseases () and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human BCL2 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
About GDU

GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.


Go to Cancer, Inflammation/autoimmune/inflammatory disease, Neurodegenerative diseases diagnostics products collection
>>
Comments
No comments yet.